New antiplatelet agents in ACS - Part I

Session comprising selected EuroPCR 2014 abstract submissions

Chairpersons: L. Di Serafino, P.G. Steg

Presentations available when logged in:

  • Upstream prasugrel loading in patients with STEMI referred for primary PCI - Does time matter?
  • Impact of new P2Y12 blockers on platelet reactivity and clinical outcomes after ACS: insight from a large single centre registry
  • Prasugrel versus Ticagrelor in ACS: a randomised comparison
  • Alternative strategies to aspirin and clopidogrel for patients presenting with ACS: a network meta-analysis